Radiologists use diagnostic imaging to non-invasively look inside the body to help determine the causes of an injury or an illness, and confirm a diagnosis. Providers use many imaging modalities to do so, including CT, MRI, X-ray, Ultrasound, PET and more.
Chest CT is routinely performed for things like lung cancer screening, coronary calcium assessment and pulmonary nodule surveillance, but the modality also can be used to extract additional information.
By highlighting subtle abnormalities that could otherwise be overlooked, an algorithm could potentially serve as an additional safety net when radiographic findings are indeterminate.
The American College of Radiology (ACR) issued a statement this week calling on the Centers for Medicare & Medicaid Services (CMS) and private insurers to cover beneficiaries for breast tomosynthesis.
And you thought 7T MRIs were powerful. Gizmodo recently ran a story about the INUMAC (Imaging of Neuro disease Using high-field MR And Contrastophores) project, a $270 million machine that clocks in at 11.75 Tesla.
While Medicare’s mammography costs increased nearly 50 percent in the early 2000s, the number of women screened and detection rates for early-stage disease remained stable.
Missouri governor Jay Nixon signed his state’s breast density notification bill this week, making Missouri the 19th state with a law requiring information on breast density is included with mammography reports given to patients.
Combining contrast-enhanced ultrasonography (US) with unenhanced US can improve the differential diagnosis of small nonpalpable testicular lesions, according to a study published online June 26 in Radiology.
It’s to be expected that more challenging mammography interpretations would decrease resident performance, but research has demonstrated that the types of errors made will vary based on whether a scan is classified as difficult by expert attending physicians or residents themselves.
The Access to Medical Imaging Coalition (AMIC) today said that a study in the June 25 issue of the Journal of the American Medical Association (JAMA) digital breast tomosynthesis (3D mammography) underscores the value of ongoing research toward improved methods of detecting and treating invasive cancer.
